Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beland

Showing results (341-350 of 698) with videos related to

Pageof 70
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 3, 2011
Nonshadowing echogenic foci in thyroid nodules: are certain appearances enough to avoid thyroid biopsy?Michael D Beland, Lawrence Kwon, Ronald A Delellis, et al.
Environmental Health Perspectives|March 1, 1993
DNA adduct formation in relation to lymphocyte mutations and lung tumor induction in F344 rats treated with the environmental pollutant 1,6-dinitropyreneB A Smith, N F Fullerton, A Aidoo, et al.
Mutation Research|February 3, 2000
Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluoreneR A Mittelstaedt, B A Smith, T Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1976
(+/-)-7alpha,8beta-dihydroxy-9beta,10beta-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene is an intermediate in the metabolism and binding to DNA of benzo(a)pyreneH W King, M R Osborne, F A Beland, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesisF F Kadlubar, Y Yamazoe, N P Lang, et al.
Biochemical Pharmacology|April 11, 2015
Mechanisms of tolvaptan-induced toxicity in HepG2 cellsYuanfeng Wu, Frederick A Beland, Si Chen, et al.
Epigenetics|November 3, 2012
Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotypeNatalie E Simpson, Volodymyr P Tryndyak, Marta Pogribna, et al.
European Journal of Radiology|July 28, 2012
Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablationTracey G Simon, Michael D Beland, Jason T Machan, et al.
Developments in Toxicology and Environmental Science|January 1, 1986
Metabolism of dinitropyrenes to DNA-binding derivatives in vitro and in vivoR H Heflich, Z Djuric, E K Fifer, et al.
Carcinogenesis|January 1, 1986
Synthesis and mutagenicity of 1-nitro-6-nitrosopyrene and 1-nitro-8-nitrosopyrene, potential intermediates in the metabolic activation of 1,6- and 1,8-dinitropyreneE K Fifer, R H Heflich, Z Djurić, et al.
Pageof 70

Showing results (341-350 of 698) with videos related to

Sort By:
Pageof 70
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 3, 2011
Nonshadowing echogenic foci in thyroid nodules: are certain appearances enough to avoid thyroid biopsy?Michael D Beland, Lawrence Kwon, Ronald A Delellis, et al.
Environmental Health Perspectives|March 1, 1993
DNA adduct formation in relation to lymphocyte mutations and lung tumor induction in F344 rats treated with the environmental pollutant 1,6-dinitropyreneB A Smith, N F Fullerton, A Aidoo, et al.
Mutation Research|February 3, 2000
Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluoreneR A Mittelstaedt, B A Smith, T Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1976
(+/-)-7alpha,8beta-dihydroxy-9beta,10beta-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene is an intermediate in the metabolism and binding to DNA of benzo(a)pyreneH W King, M R Osborne, F A Beland, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesisF F Kadlubar, Y Yamazoe, N P Lang, et al.
Biochemical Pharmacology|April 11, 2015
Mechanisms of tolvaptan-induced toxicity in HepG2 cellsYuanfeng Wu, Frederick A Beland, Si Chen, et al.
Epigenetics|November 3, 2012
Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotypeNatalie E Simpson, Volodymyr P Tryndyak, Marta Pogribna, et al.
European Journal of Radiology|July 28, 2012
Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablationTracey G Simon, Michael D Beland, Jason T Machan, et al.
Developments in Toxicology and Environmental Science|January 1, 1986
Metabolism of dinitropyrenes to DNA-binding derivatives in vitro and in vivoR H Heflich, Z Djuric, E K Fifer, et al.
Carcinogenesis|January 1, 1986
Synthesis and mutagenicity of 1-nitro-6-nitrosopyrene and 1-nitro-8-nitrosopyrene, potential intermediates in the metabolic activation of 1,6- and 1,8-dinitropyreneE K Fifer, R H Heflich, Z Djurić, et al.
Pageof 70